Drug Profile


Alternative Names: BMS 181161; Calcipotriene; Daivonex; Dovonex; Dovonex Cream; Dovonex Ointment; Dovonex Scalp Solution; MC 903; Psorcutan

Latest Information Update: 10 Sep 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator LEO Pharma
  • Class Antipsoriatics; Cyclohexanes; Dihydroxycholecalciferols; Indenes; Vitamin D analogues
  • Mechanism of Action Calcitriol receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Marketed Psoriasis

Most Recent Events

  • 30 Apr 2016 Polichem SA completes a phase I trial in Healthy volunteers in Switzerland (ISRCTN13465335)
  • 29 Apr 2016 Biomarkers information updated
  • 11 Dec 2015 Polichem SA plans a phase I trial in Healthy volunteers in Switzerland (ISRCTN13465335)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top